InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Mauro David J, Directeur Médical. Insider active across 1 companies, notably Prelude Therapeutics Inc. Cumulatively, 12 filings have been published. The latest transaction was disclosed on 5 October 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€24,44815,000 shares@ €1.62990.0069% mcap17.1% of flow
Common Stock
SEC:0001209191-21-059850·
€24,44815,000 shares@ €1.62990.0069% mcap8.5% of flow
Common Stock
SEC:0001209191-21-059850:0·
€23,93715,000 shares@ €1.59580.0067% mcap16.7% of flow
Common Stock
SEC:0001209191-21-055307·
€23,93715,000 shares@ €1.59580.0067% mcap8.4% of flow
Common Stock
SEC:0001209191-21-055307:0·
€23,95315,000 shares@ €1.59690.0067% mcap16.7% of flow
Common Stock
SEC:0001209191-21-050404·
€23,95315,000 shares@ €1.59690.0067% mcap8.4% of flow
Common Stock
SEC:0001209191-21-050404:0·
€23,97615,000 shares@ €1.59840.0067% mcap16.7% of flow
Common Stock
SEC:0001209191-21-046013·
€23,97615,000 shares@ €1.59840.0067% mcap8.4% of flow
Common Stock
SEC:0001209191-21-046013:0·
€23,25015,000 shares@ €1.550.0065% mcap8.1% of flow
Common Stock
SEC:0001209191-21-039261:0·
€23,25015,000 shares@ €1.550.0065% mcap16.2% of flow
Common Stock
SEC:0001209191-21-039261·
€23,60915,000 shares@ €1.5740.0066% mcap16.5% of flow
Common Stock
SEC:0001209191-21-031248·
€23,60915,000 shares@ €1.5740.0066% mcap8.2% of flow
Common Stock
SEC:0001209191-21-031248:0·
12 of 12 declarations
About Mauro David J
David J. Mauro is the Chief Medical Officer at Prelude Therapeutics Inc. In this role, he oversees the company's medical and clinical initiatives. Mauro brings significant expertise in the medical field, contributing to innovation and the improvement of treatments.
